Yanhong Deng
Clinical trials sponsored by Yanhong Deng, explained in plain language.
-
New chemo cocktail aims to shrink more tumors in advanced colorectal cancer
Disease control Recruiting nowThis phase 3 trial compares two chemotherapy combinations (mFOLFOXIRI vs mFOLFOX-6), both given with bevacizumab, as first treatment for people with metastatic colorectal cancer that cannot be removed by surgery. The study includes 528 adults in China and measures how long the ca…
Phase: PHASE3 • Sponsor: Yanhong Deng • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Could a chemo cocktail spare rectal cancer patients from radiation?
Disease control Recruiting nowThis study compares two treatment approaches for people with high-risk locally advanced rectal cancer. One group gets a strong three-drug chemo plus a targeted therapy (bevacizumab), and only receives radiation if needed. The other group gets standard chemo followed by chemoradia…
Phase: PHASE3 • Sponsor: Yanhong Deng • Aim: Disease control
Last updated May 18, 2026 12:02 UTC